5-HT1A receptor antagonist

This page covers all 5-HT1A receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-HT1A receptor.

Targets

5-HT1A receptor

Phase 3 pipeline (1)

• URAPIDIL (EUPRESSYL*) · University Hospital, Strasbourg, France · Cardiovascular
  Urapidil is a selective and competitive antagonist of the 5-HT1A receptor.

Patent intelligence

• 5 ht1a receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates